|
|
|
Volumn 7, Issue , 2004, Pages 1-54
|
|
Reference pricing of pharmaceuticals for Medicare: evidence from Germany, The Netherlands, and New Zealand.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG;
GENERIC DRUG;
CLASSIFICATION;
COMPARATIVE STUDY;
COST;
COST CONTROL;
DRUG COST;
DRUG INDUSTRY;
ECONOMIC ASPECT;
ECONOMICS;
GERMANY;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HUMAN;
MARKETING;
MEDICAL LITERATURE;
MEDICARE;
METHODOLOGY;
MULTIVARIATE ANALYSIS;
NETHERLANDS;
NEW ZEALAND;
ORGANIZATION AND MANAGEMENT;
PUBLIC HEALTH;
REIMBURSEMENT;
REVIEW;
STANDARD;
STATISTICAL MODEL;
STATISTICS;
UNITED STATES;
COST CONTROL;
COSTS AND COST ANALYSIS;
DRUG COSTS;
DRUG INDUSTRY;
DRUGS, GENERIC;
ECONOMIC COMPETITION;
EFFICIENCY, ORGANIZATIONAL;
GERMANY;
HEALTH POLICY;
HUMANS;
INSURANCE, PHARMACEUTICAL SERVICES;
MARKETING;
MEDICARE;
MODELS, ECONOMIC;
MULTIVARIATE ANALYSIS;
NATIONAL HEALTH PROGRAMS;
NETHERLANDS;
NEW ZEALAND;
PHARMACEUTICAL PREPARATIONS;
PHARMACOPOEIAS;
REFERENCE STANDARDS;
REIMBURSEMENT MECHANISMS;
REIMBURSEMENT, INCENTIVE;
UNITED STATES;
|
|
EID: 15244359182
PISSN: 1096231X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (69)
|
|
References (32)
|
